438 related articles for article (PubMed ID: 26274827)
1. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
[TBL] [Abstract][Full Text] [Related]
2. A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO
Cicero AFG; D'Addato S; Borghi C
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066334
[TBL] [Abstract][Full Text] [Related]
3. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
[TBL] [Abstract][Full Text] [Related]
4. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
5. Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.
Becker DJ; French B; Morris PB; Silvent E; Gordon RY
Am Heart J; 2013 Jul; 166(1):187-96. PubMed ID: 23816039
[TBL] [Abstract][Full Text] [Related]
6. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
[TBL] [Abstract][Full Text] [Related]
7. Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice.
Lee CY; Jan MS; Yu MC; Lin CC; Wei JC; Shih HC
Forsch Komplementmed; 2013; 20(3):197-203. PubMed ID: 23860021
[TBL] [Abstract][Full Text] [Related]
8. LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
Magno S; Ceccarini G; Pelosini C; Jaccheri R; Vitti J; Fierabracci P; Salvetti G; Airoldi G; Minale M; Saponati G; Santini F
Lipids Health Dis; 2018 May; 17(1):124. PubMed ID: 29793488
[TBL] [Abstract][Full Text] [Related]
9. Powdered red yeast rice and plant stanols and sterols to lower cholesterol.
Feuerstein JS; Bjerke WS
J Diet Suppl; 2012 Jun; 9(2):110-5. PubMed ID: 22531006
[TBL] [Abstract][Full Text] [Related]
10. The short-term supplementation of monacolin K improves the lipid and metabolic patterns of hypertensive and hypercholesterolemic subjects at low cardiovascular risk.
Mazza A; Schiavon L; Rigatelli G; Torin G; Montanaro F; Lenti S
Food Funct; 2018 Jul; 9(7):3845-3852. PubMed ID: 29951651
[TBL] [Abstract][Full Text] [Related]
11. A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.
Barrat E; Zaïr Y; Ogier N; Housez B; Vergara C; Maudet C; Lescuyer JF; Bard JM; Carpentier YA; Cazaubiel M; Peltier SL
Int J Food Sci Nutr; 2013 Nov; 64(7):882-9. PubMed ID: 23815518
[TBL] [Abstract][Full Text] [Related]
12. Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.
Cicero AFG; Fogacci F; Bove M; Veronesi M; Rizzo M; Giovannini M; Borghi C
Adv Ther; 2017 Aug; 34(8):1966-1975. PubMed ID: 28687937
[TBL] [Abstract][Full Text] [Related]
13. Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial.
Ferguson JJA; Stojanovski E; MacDonald-Wicks L; Garg ML
Metabolism; 2018 May; 82():22-35. PubMed ID: 29291429
[TBL] [Abstract][Full Text] [Related]
14. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease.
Earnest CP; Mikus CR; Lemieux I; Arsenault BJ; Church TS
Nutrition; 2007 Sep; 23(9):625-33. PubMed ID: 17644340
[TBL] [Abstract][Full Text] [Related]
15. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
[TBL] [Abstract][Full Text] [Related]
16. Effects of monacolin K-containing nutraceutical on cholesterol homeostasis re-establishment and CVD risk reduction in hypercholesterolemic subjects.
Gojkovic T; Vladimirov S; Kotur-Stevuljevic J; Bogavac-Stanojevic N; Zeljkovic A; Vekic J; Antonic T; Spasojevic-Kalimanovska V
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5261-5267. PubMed ID: 34486702
[TBL] [Abstract][Full Text] [Related]
17. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar.
Cicero AFG; Fogacci F; Zambon A
J Am Coll Cardiol; 2021 Feb; 77(5):620-628. PubMed ID: 33538260
[TBL] [Abstract][Full Text] [Related]
18. Lipid effects of a dietary supplement softgel capsule containing plant sterols/stanols in primary hypercholesterolemia.
Maki KC; Lawless AL; Reeves MS; Kelley KM; Dicklin MR; Jenks BH; Shneyvas E; Brooks JR
Nutrition; 2013 Jan; 29(1):96-100. PubMed ID: 22796122
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Marazzi G; Cacciotti L; Pelliccia F; Iaia L; Volterrani M; Caminiti G; Sposato B; Massaro R; Grieco F; Rosano G
Adv Ther; 2011 Dec; 28(12):1105-13. PubMed ID: 22113535
[TBL] [Abstract][Full Text] [Related]
20. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
